179 related articles for article (PubMed ID: 2784491)
21. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
[TBL] [Abstract][Full Text] [Related]
22. 2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug.
O'Dwyer PJ; Wagner B; Leyland-Jones B; Wittes RE; Cheson BD; Hoth DF
Ann Intern Med; 1988 May; 108(5):733-43. PubMed ID: 3282467
[TBL] [Abstract][Full Text] [Related]
23. Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group.
Döhner H; Ho AD; Thaler J; Stryckmans P; Sonneveld P; de Witte T; Lechner K; Lauria F; Bödewadt-Radzun S; Suciu S
J Natl Cancer Inst; 1993 Apr; 85(8):658-62. PubMed ID: 8468724
[TBL] [Abstract][Full Text] [Related]
24. Deoxycoformycin in the treatment of leukemias and lymphomas.
Smyth JF; Prentice HG; Proctor S; Hoffbrand AV
Ann N Y Acad Sci; 1985; 451():123-8. PubMed ID: 3878113
[TBL] [Abstract][Full Text] [Related]
25. Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.
Poplack DG; Sallan SE; Rivera G; Holcenberg J; Murphy SB; Blatt J; Lipton JM; Venner P; Glaubiger DL; Ungerleider R; Johns D
Cancer Res; 1981 Sep; 41(9 Pt 1):3343-6. PubMed ID: 6973390
[TBL] [Abstract][Full Text] [Related]
26. Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin).
Spiers AS; Parekh SJ; Bishop MB
J Clin Oncol; 1984 Dec; 2(12):1336-42. PubMed ID: 6334721
[TBL] [Abstract][Full Text] [Related]
27. The treatment of hairy-cell leukaemia with 2'-deoxycoformycin.
Johnston JB; Glazer RI; Pugh L; Israels LG
Br J Haematol; 1986 Jul; 63(3):525-34. PubMed ID: 3488071
[TBL] [Abstract][Full Text] [Related]
28. Treatment of cutaneous T cell lymphoma with 2'-deoxycoformycin (pentostatin).
Dang-Vu AP; Olsen EA; Vollmer RT; Greenberg ML; Hershfield MS
J Am Acad Dermatol; 1988 Oct; 19(4):692-8. PubMed ID: 3263401
[TBL] [Abstract][Full Text] [Related]
29. Clinical pharmacology of deoxycoformycin.
Major PP; Agarwal RP; Kufe DW
Blood; 1981 Jul; 58(1):91-6. PubMed ID: 6263381
[TBL] [Abstract][Full Text] [Related]
30. Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo.
Ho AD; Ganeshaguru K; Knauf WU; Dietz G; Trede I; Hunstein W; Hoffbrand AV
Blood; 1988 Dec; 72(6):1884-90. PubMed ID: 3264192
[TBL] [Abstract][Full Text] [Related]
31. Modulation of arabinosyladenine metabolism by 2'-deoxycoformycin in the therapy of human acute leukemia.
Plunkett W; Nowak B; Feun LG; Benjamin RS; Keating M; Freirich EJ
Adv Exp Med Biol; 1984; 165 Pt B():345-50. PubMed ID: 6372382
[No Abstract] [Full Text] [Related]
32. Phenotypic conversion of acute leukaemia from T-lymphoblastic to myeloblastic induced by therapy with 2'-deoxycoformycin.
Murphy SB; Stass S; Kalwinsky D; Rivera G
Br J Haematol; 1983 Oct; 55(2):285-93. PubMed ID: 6604543
[TBL] [Abstract][Full Text] [Related]
33. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
[TBL] [Abstract][Full Text] [Related]
34. Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia.
Dillman RO; Yu AL; Qiao CN
West J Med; 1988 Mar; 148(3):334-7. PubMed ID: 3259051
[No Abstract] [Full Text] [Related]
35. The treatment of hairy cell leukemia with 2'-deoxycoformycin: results in India and in the United States.
Spiers AS; Parekh SJ
Leukemia; 1987 Apr; 1(4):347-50. PubMed ID: 3499541
[TBL] [Abstract][Full Text] [Related]
36. Pentostatin, chlorambucil and prednisone therapy for B-chronic lymphocytic leukemia: a phase I/II study by the Eastern Cooperative Oncology Group study E1488.
Oken MM; Lee S; Kay NE; Knospe W; Cassileth PA
Leuk Lymphoma; 2004 Jan; 45(1):79-84. PubMed ID: 15061201
[TBL] [Abstract][Full Text] [Related]
37. Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2'-deoxycoformycin in vivo and in vitro.
Begleiter A; Glazer RI; Israels LG; Pugh L; Johnston JB
Cancer Res; 1987 May; 47(9):2498-503. PubMed ID: 3494509
[TBL] [Abstract][Full Text] [Related]
38. Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin.
Hershfield MS; Kurtzberg J; Harden E; Moore JO; Whang-Peng J; Haynes BF
Proc Natl Acad Sci U S A; 1984 Jan; 81(1):253-7. PubMed ID: 6607471
[TBL] [Abstract][Full Text] [Related]
39. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
[TBL] [Abstract][Full Text] [Related]
40. What is the choice of treatment for hairy cell leukemia?
Golomb HM; Ratain MJ; Moormeier J
J Clin Oncol; 1989 Feb; 7(2):156-8. PubMed ID: 2783730
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
